https://www.selleckchem.com/products/rmc-9805.html
Embolization of the middle meningeal artery for treatment of refractory or recurrent chronic subdural hematomas has gained momentum during the past few years. Little has been reported on the use of the -BCA liquid embolic system for middle meningeal artery embolization. We present the technical feasibility of using diluted -BCA for middle meningeal artery embolization. We sought to examine the safety and technical feasibility of the diluted -BCA liquid embolic system for middle meningeal artery embolization. Patients with chronic refra
Like
Comment
Share
